TCM promotes the growth and quality of the technology
and life sciences communities in Maryland and the
region by providing outstanding education, advocacy
and business networking opportunities.
MdBio

MdBio Foundation

History

In 1991, a non-profit organization called Maryland Bioprocessing Center, Inc. (now MdBio) was created as part of an initiative to enhance Maryland’s burgeoning bioscience industry and infrastructure through the construction of a state-of-the-art multi-tenant biomanufacturing facility. After raising $18,000,000 through state and federal grants and $3,000,000 in private funding, BioCenter construction commenced.

The BioCenter, a 54,000 square foot GMP facility owned by Maryland Bioprocessing Center, was completed in 1996 on land leased from the City of Baltimore just off the Johns Hopkins Bayview Research Campus. Shortly after completing construction, the non-profit negotiated a long-term lease with Bio Science Contract Production Corp (BSCP), a contract biomanufacturing company. In 2000, BSCP was sold to Cambrex Corporation, which assumed the lease on the facility. In 2007, Cambrex was sold to Lonza

With revenue from the lease payments, the non-profit organization has used its financial resources to support and promote the commercial development of bioscience in Maryland. MdBio assumed its current name in July 1997 to better reflect the organization’s focus on developing industry support programs intended to advance the growth of bioscience in Maryland. Since that time, MdBio has been instrumental in the continued growth of Maryland’s bioscience industry, providing companies with financial support, business development consulting services, cost-sharing and group purchasing opportunities, as well as education and workforce development programs.

In 2006, MdBio merged with the Tech Council of Maryland (TCM) to form TCM/MdBio. As a result of this merger, two organizations were formed, The MdBio Division of TCM/MdBio and the MdBio Foundation.

Mission

The MdBio foundation is a private non-profit organization dedicated to advancing the growth of bioscience in Maryland through a variety of programs, with a special emphasis on education, training and communications.

MdBio Foundation Board of Directors (as of 12/21/07)

Chairman
James K. Leslie

Partner Cabot Consultants

email

Board Members

Sherri Bale, PhD President

GeneDx

email

Henry Bernstein
Senior Vice President

Scheer Partners

email

Julie Coons
Chief Executive Officer

Tech Council of Maryland/MdBio
9713 Key West Avenue, Suite 100
Rockville, MD 20850

240.243.4080 [ph]
email

Stanley C. Erck
President and CEO

Iomai Corporation

email

Patrick Hervy
Chair

XL Health

email

John W. Holaday
Managing Director and CEO

QRxPharma

email

Jennie C. Hunter-Cervera
President

Univ of Maryland Biotechnology Institute

email

Rachel K. King
Chief Executive Officer

GlycoMimetics, Inc.

email

Gary McGarrity, PhD
Executive Vice-President

Virxsys

email

Theodore Poehler
Vice Provost for Research

The Johns Hopkins University

email

Edward M. Rudnic
President and Chief Executive Officer

MiddleBrook Pharmaceuticals

email

Phillip A. Singerman
Senior Vice President

B&D Consulting

email

Samuel (Sandy) B. Sterrett, Jr.

Foley & Lardner LLP

email

John J. Woloszyn
Vice President & General Counsel

Intralytix, Inc.

email

Benjamin H. Wu
Assistant Secretary, Capital Region

MD Dept. of Business and Economic Devel

email

Richard A. Zakour, Executive Director
Jen Colvin, Director of Education and Workforce Programs
Blanche Johnson, Investment Advisor to the Board
Barbara Weitzer, Secretary to the Board